2 ms·
The biosimiliar insulin initiative is a very big deal, but for context it is not CalRx's first effort to reach public availability. That was the Naloxone Initia
by dragonwriter 1y ago
The biosimiliar insulin initiative is a very big deal, but for context it is not CalRx's first effort to reach public availability. That was the Naloxone Initiative, which made OTC naloxone (generic for Narcan), which hit the market last year at about 40% below the pre-existing market price, and has dropped further since.